Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8779-8789
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8779
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8779
Figure 4 Correlation between the expression of macrophage colony-stimulating factor and CD163, or CD31 in the non-tumoral liver tissues.
Immunohistochemical staining for macrophage colony-stimulating factor (M-CSF), CD163, and CD31 was performed in non-cancerous liver tissue collected from patients as described in detail in the Patients and Methods section. A (between M-CSF and CD163) and B (between M-CSF and CD31) show correlations between markers assessed in this study in each of the patients with HCC.
- Citation: Kono H, Fujii H, Furuya S, Hara M, Hirayama K, Akazawa Y, Nakata Y, Tsuchiya M, Hosomura N, Sun C. Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma. World J Gastroenterol 2016; 22(39): 8779-8789
- URL: https://www.wjgnet.com/1007-9327/full/v22/i39/8779.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i39.8779